EN
HI
Divi's Laboratories Share Price
DIVISLAB
11180.52.50 (0.02%)
NSE
BSE
Free Demat with Zero AMC*
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
Summary
As of 22 Nov, 2026, Divi's Laboratories stock price is ₹11180.5. During the trading session, the stock has moved between an intraday low of ₹11025.00 and an intraday high of ₹11198.00. Over the last 52 weeks, Divi's Laboratories has traded between ₹5647.50 and ₹11824.00.
The stock has recorded a trading volume of 4,04,825 shares,. Its Average Traded Price (ATP) is ₹11113.02, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 5 @ ₹11180.50.
Divi's Laboratories has an upper circuit limit of ₹11473.00 and a lower circuit limit of ₹10805.00. The total value traded stands at ₹449.88 CR, and the delivery percentage for the day is 66.43%.
The stock is currently traded with a market lot size of 1. Divi's Laboratories also offers a dividend yield of 0.27%.
Divi's Laboratories Share Price Chart
Divi's Laboratories Share Key Metrics
Volume
4.05 L
Market Cap
296807.15 CR
LTQ@LTP
5@11180.50
ATP
11113.02
Var Margin
14.14 %
Circuit Range
10805-11473
Delivery %
66.43 %
Value
449.88 CR
ASM/GSM
No
Market Lot
1
Divi's Laboratories Resistance and Support
Pivot 11107
Resistance
First Resistance
11249
Second Resistance
11320
Third Resistance
11462
Support
First Support
11036
Second Support
10894
Third Support
10823
Divi's Laboratories Futures & Options
11180.5
2.5 (0.02%)
Divi's Laboratories Option Chain
View Price, OI, Greeks & More...
23NOV26
0.00
NaN (%)
29DEC26
0.00
NaN (%)
25JAN27
0.00
NaN (%)
DIVISLAB|23NOV26 CE 11100.00
55.00
-65.6 (-54.39%)
DIVISLAB|23NOV26 PE 11200.00
129.45
-5.3 (-3.93%)
Divi's Laboratories Shareholding Pattern
View More- 2016-17
- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Segment
Percent
Total Promoters
51.88%
Mutual Fund
14.66%
Insurance
3.48%
Foreign Institutional Investors
20.38%
Domestic Institutional Investors
1.03%
Retail
8.58%
Others
-0.01%
Total Promoters
MAR '26
51.88%
JUN '26
51.88%
SEP '26
51.88%
Divi's Laboratories Corporate Actions
| Date | Agenda |
|---|---|
| 2026-11-07 | Quarterly Results |
| 2026-08-01 | Quarterly Results |
| 2026-05-23 | Audited Results & Dividend |
| 2026-02-11 | Quarterly Results |
| 2025-11-07 | Quarterly Results |
| 2025-08-06 | Quarterly Results |
| 2025-05-17 | Audited Results & Dividend |
| 2025-02-03 | Quarterly Results |
| 2024-11-09 | Quarterly Results |
| 2024-08-03 | Quarterly Results |
| Ex Date | Record Date | |
|---|---|---|
| 2026-07-24 | 2026-07-24 | View More |
Divi's Laboratories News
Divis Laboratories Ltd - 532488 - Board Meeting Outcome for Outcome Of Board Meeting Held On 07.11.2026 - Financial Results For The Quarter And Half Year Ended September 30, 2026.
Divi's Laboratories reported Q2 FY27 cons. total income of ₹3,770 crores, up 31.8% YoY, and net profit of ₹1,127 crores, up 63.5% YoY. The performance included a forex gain of ₹24 crores for the quarter.
Nov 07 2026 11:59:15
Divi's Laboratories Management
| Name | Position |
|---|---|
| M Satish Choudhury | Company Secretary & Compliance Officer |
| Murali K Divi | Managing Director |
Divi's Laboratories Similar Stocks
Sun Pharmaceutical Industries Ltd.
1884.90
-15.10 (0.79%)
Torrent Pharmaceuticals Ltd.
4689.50
78.50 (1.70%)
Lenskart Solutions Ltd.
744.35
2.70 (0.36%)
Apollo Hospitals Enterprise Ltd.
9200.00
462.00 (5.29%)
Laurus Labs Ltd.
2294.60
-11.40 (0.49%)
Zydus Lifesciences Ltd.
1200.00
-2.90 (0.24%)
Dr. Reddy's Laboratories Ltd.
1390.20
-10.70 (0.76%)
Cipla Ltd.
1415.00
-3.50 (0.25%)
Mankind Pharma Ltd.
2665.00
36.00 (1.37%)
Aurobindo Pharma Ltd.
1799.00
-6.70 (0.37%)
Divi's Laboratories FAQs
The Buying Price of Divi's Laboratories share is 11180.5 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Divi's Laboratories stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Divi's Laboratories, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Divi's Laboratories shares is 88.41. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Divi's Laboratories shares is 16.52. Useful to assess the stock's value relative to its book value.
To assess Divi's Laboratories’s valuation compare Sector P/E, P/B which are 39.61 & 2.57 with sector averages, along with growth rates and financial metrics.
The Market Cap of Divi's Laboratories is 296807.15 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Divi's Laboratories share price is 11824.00 & 5647.50. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Divi's Laboratories belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in DIVISLAB
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC